Katharine Knobil
Equibles does not estimate personal net worth.
About Katharine Knobil
Earlier roles on record: Board Member at Pliant Therapeutics, Inc. (PLRX) until April 17, 2026. Pliant Therapeutics, Inc. reported in an 8-K filed April 17, 2026 that Katharine Knobil retired as Class II director on the Board.
“On April 16, 2026, Katharine Knobil, M.D., a Class II director on the Board and the Chair of the Research and Development Committee and a member of the Nominating and Corporate Governance Committee of the Board, notified the Chief Executive Officer of the Company, Chairman of the Board, and Chair of the Nominating and Corporate Governance Committee of her retirement from the Board and all committees thereof, effective as of the Annual Meeting.”
Affiliation history
-
2022-01-01–2026-04-17